16-074
Showing 1 - 25 of 5,474
COVID-19 Trial in Worldwide (AZD7442, Placebo, Remdesivir)
Active, not recruiting
- COVID-19
- AZD7442
- +2 more
-
Tucson, Arizona
- +123 more
Mar 24, 2023
COVID-19 Trial in Worldwide (BRII-196, BRII-198, Placebo)
Completed
- COVID-19
- BRII-196
- +3 more
-
Tucson, Arizona
- +106 more
Mar 24, 2023
COVID-19 Trial in Worldwide (VIR-7831, Placebo, Remdesivir)
Completed
- COVID-19
- VIR-7831
- +2 more
-
Tucson, Arizona
- +104 more
Mar 22, 2023
COVID-19 Trial in Worldwide (LY3819253, Placebo, Remdesivir)
Completed
- COVID-19
- LY3819253
- +2 more
-
Tucson, Arizona
- +56 more
Mar 22, 2023
Covid19 Trial in Brazil, United States (Remdesivir, Remdesivir Placebo, Aviptadil)
Completed
- Covid19
- Remdesivir
- +4 more
-
Tucson, Arizona
- +39 more
Dec 16, 2022
Prostate Cancer, Castration Resistant Prostate Cancer Trial in United States (Enzalutamide, CC-115)
Active, not recruiting
- Prostate Cancer
- Castration Resistant Prostate Cancer
-
San Francisco, California
- +4 more
Mar 18, 2022
Lupus Nephritis Trial in Hong Kong (Pre-emptive increase of immunosuppressive treatments, Prednisolone and/or AZA/MMF)
Recruiting
- Lupus Nephritis
- Pre-emptive increase of immunosuppressive treatments
- Prednisolone and/or AZA/MMF
-
Hong Kong, Hong Kong
- +1 more
Jul 25, 2022
Healthy Trial in Winnipeg (transcranial direct current stimulation)
Active, not recruiting
- Healthy
- transcranial direct current stimulation
-
Winnipeg, Manitoba, CanadaUniversity of Manitoba
Oct 31, 2022
Type 1 Diabetes Trial in Puerto Rico, United States (HOE901-U300 (Insulin Glargine 300 U/ml), Lantus (Insulin Glargine 100
Completed
- Type 1 Diabetes Mellitus
- HOE901-U300 (Insulin Glargine 300 U/ml)
- +2 more
-
Little Rock, Arkansas
- +99 more
Mar 21, 2022
Refractory Epilepsy, Deep Brain Stimulation Trial in Minneapolis (PS and OS stimulation order 1, PS and OS stimulation order 2,
Not yet recruiting
- Refractory Epilepsy
- Deep Brain Stimulation
- PS and OS stimulation order 1
- +2 more
-
Minneapolis, MinnesotaUniversity of Minnesota
Aug 5, 2022
Eosinophilic Asthma, Asthma; Eosinophilic, Asthma Attack Trial in United States (Dexpramipexole DiHCl, Placebo)
Recruiting
- Eosinophilic Asthma
- +2 more
- Dexpramipexole Dihydrochloride
- Placebo
-
West Covina, California
- +7 more
Mar 1, 2023
Non-Cystic Fibrosis Bronchiectasis Trial in Worldwide (Brensocatib 10 mg, Brensocatib 25 mg, Placebo)
Recruiting
- Non-Cystic Fibrosis Bronchiectasis
- Brensocatib 10 mg
- +2 more
-
Birmingham, Alabama
- +416 more
Jan 24, 2023
Idiopathic Pulmonary Fibrosis, Fibrosis, Idiopathic Interstitial Pneumonias Trial in Worldwide (CC-90001, Placebo)
Completed
- Idiopathic Pulmonary Fibrosis
- +6 more
- CC-90001
- Placebo
-
Loma Linda, California
- +94 more
Feb 4, 2022
ADHD, Dyslexia Trial in New Haven (Atomoxetine, Placebo)
Completed
- Attention Deficit Hyperactivity Disorder
- Dyslexia
- Atomoxetine
- Placebo
-
New Haven, ConnecticutYale University School of Medicine
Oct 9, 2022
Hidradenitis Suppurativa Trial in Worldwide (Imsidolimab, Placebo Solution)
Active, not recruiting
- Hidradenitis Suppurativa
- Imsidolimab
- Placebo Solution
-
Birmingham, Alabama
- +33 more
Sep 19, 2022
Risk Stratifications for Patients With Palpitations
Not yet recruiting
- Arrhythmias, Cardiac
- (no location specified)
Oct 22, 2023
Role of Novel ILR in the Management of PVCs
Recruiting
- PVC - Premature Ventricular Contraction
- Myocarditis
- Monitoring of patients presenting with PVCs
-
Overland Park, Kansas
- +5 more
Sep 27, 2023
Erectile Dysfunction Trial in Worldwide (MED3000, Tadalafil 5mg)
Completed
- Erectile Dysfunction
- MED3000
- Tadalafil 5mg
-
Baltimore, Maryland
- +17 more
Jul 26, 2022
Aortic Valve Stenosis Trial in San Donato Milanese (TAVR (Transcatheter Aortic Valve Replacement), AVR (Aortic Valve
Recruiting
- Aortic Valve Stenosis
- TAVR (Transcatheter Aortic Valve Replacement)
- AVR (Aortic Valve Replacement)
-
San Donato Milanese, MI, ItalyIRCCS Policlinico San Donato
Mar 10, 2023
Core Binding Factor Acute Myeloid Leukemia, KIT Mutation-Related Tumors Trial in Suzhou (Avapritinib)
Recruiting
- Core Binding Factor Acute Myeloid Leukemia
- KIT Mutation-Related Tumors
-
Suzhou, Jiangsu, ChinaFirst Affiliated Hospital of Soochow University
Apr 7, 2023
Quality of Life, Dysphagia Trial in Barcelona (EORTC QLQ-C30, EORTC QLQ-OG25, GIQLI)
Recruiting
- Quality of Life
- Dysphagia
- EORTC QLQ-C30
- +4 more
-
Barcelona, SpainHospital Uversitari de Bellvitge
Mar 27, 2023
Osteoarthritis, Knee, Osteoarthritis, Hip Trial in Worldwide (Fasinumab, Naproxen, Fasinumab-matching )
Completed
- Osteoarthritis, Knee
- Osteoarthritis, Hip
- Fasinumab
- +3 more
-
Mesa, Arizona
- +138 more
Oct 18, 2022
Infant Development Trial (Infant Formula)
Not yet recruiting
- Infant Development
- Infant Formula
- (no location specified)
Jul 17, 2023